Workflow
Nexalin Technology Participates in Congressional Roundtable Focused on Emerging Virtual Therapeutic Options for Opioid Treatment
Nexalin TechnologyNexalin Technology(US:NXL) GlobeNewswire News Roomยท2024-09-05 13:00

Core Insights - Nexalin Technology, Inc. participated in a Congressional roundtable in North Carolina focused on virtual therapeutic options for opioid treatment, highlighting its commitment to addressing the opioid crisis [1][2][3] Group 1: Congressional Roundtable - The roundtable was hosted by the Breaking Barriers for Substance Use Recovery initiative and included key stakeholders from healthcare and policy sectors [1] - U.S. Congressman Dr. Greg Murphy, an advocate for innovative healthcare solutions, led discussions on deploying virtual-based opioid therapy models nationwide [2] - The event aimed to address the stigma and geographic barriers associated with traditional in-clinic treatment options [3] Group 2: Nexalin's Role and Technology - Nexalin's virtual therapeutic solutions were emphasized as promising tools in combating opioid addiction, pending FDA clearance [3] - The company aims to provide effective and accessible treatment options, particularly for veterans in rural communities [4] - Nexalin's neurostimulation technology is designed to penetrate deep brain structures associated with mental health disorders, potentially enhancing patient response without adverse side effects [5] Group 3: Industry Implications - Discussions at the roundtable focused on improving practices within the Department of Veterans Affairs (VA) and the Substance Abuse and Mental Health Services Administration (SAMHSA) to promote virtual therapies [4] - The meeting aligns with Nexalin's efforts to expand its influence within U.S. Government areas of interest, particularly in mental health care [4]